ESMO ASIA

The ESMO Asia Congress (ESMO ASIA) is the most influential and authoritative annual event in oncology in the Asian region, organized by the globally renowned European Society for Medical Oncology (ESMO). ESMO, as a leading global professional oncology organization, has an excellent reputation in oncology research, education, and clinical practice. The ESMO Asia Congress upholds ESMO's high standards and rigor worldwide, dedicated to providing a top-tier learning, exchange, and collaboration platform for oncology professionals in the Asia-Pacific region. Each year, the congress brings together top experts, clinicians, researchers, patient advocates, and pharmaceutical industry representatives from around the world to discuss the latest advancements, cutting-edge technologies, and future trends in oncology. The congress is grand in scale, attracting over 23,000 professionals annually, making the ESMO Asia Congress an unparalleled opportunity for knowledge sharing and networking. Attendees can learn about the latest breakthroughs in basic research, innovative applications of cancer immunotherapy, best practices in oncology care, advances in palliative care, as well as diagnostic and treatment strategies for rare cancers and updates on new drug approvals. The scientific program of the congress is meticulously planned by a committee of over 300 international experts, ensuring that the content covers all aspects of oncology, from basic science to clinical application, from diagnosis to treatment, from prevention to rehabilitation. This comprehensive content coverage makes the ESMO Asia Congress a key platform for oncology professionals to acquire the latest knowledge, enhance professional skills, and establish connections with international peers. Through the ESMO Asia Congress, oncology professionals in the Asia-Pacific region can keep pace with the rapid development of global oncology science and education, jointly promoting improvements in cancer patient care.

The ESMO Asia Congress, as a comprehensive event in oncology, covers a wide range of exhibits and discussion topics across oncology research, diagnosis, treatment, care, and supportive therapy, aiming to showcase and exchange the latest scientific breakthroughs and clinical practices. Specific exhibits and discussion categories include but are not limited to: 1. Oncology Drugs and Treatment Regimens: Covering various anti-cancer drugs such as chemotherapy drugs, targeted therapy drugs, immune checkpoint inhibitors, cell therapy (e.g., CAR-T cell therapy), gene therapy, etc. Also includes novel drug delivery systems, combination therapy regimens, individualized treatment strategies, and precision medicine-related drugs. 2. Oncology Diagnosis and Screening Technologies: Involving early cancer screening technologies, molecular diagnostic technologies (e.g., gene sequencing, liquid biopsy), imaging diagnostic equipment (e.g., PET/CT, MRI, ultrasound), pathological diagnostic technologies, biomarker detection, etc., aimed at improving the early diagnosis rate and accuracy of cancer. 3. Radiation Therapy Equipment and Technologies: Including advanced radiotherapy equipment such as linear accelerators, gamma knives, proton therapy, heavy ion therapy, as well as radiotherapy planning systems, dosimetry software, radiation protection equipment, etc., showcasing the latest advancements in radiation therapy for cancer treatment. 4. Surgical Instruments and Technologies: Covering minimally invasive surgical instruments, robotic-assisted surgical systems, endoscopes, laser surgical equipment, intraoperative navigation systems, as well as innovative technologies and concepts in oncological surgery. 5. Oncology Care and Palliative Care: Involving products and services for cancer patient pain management, nutritional support, psychological counseling, rehabilitation therapy, end-of-life care, aimed at improving the quality of life for cancer patients. 6. Research Tools and Laboratory Equipment: Including various life science research instruments, cell culture equipment, genomics and proteomics research platforms, bioinformatics analysis tools, laboratory consumables, etc., supporting basic oncology research and translational medicine. 7. Medical Information Technology and Digital Solutions: Covering electronic medical record systems, telemedicine platforms, AI-assisted diagnostic systems, big data analysis tools, clinical trial management systems, etc., promoting the intelligent and efficient development of oncology medicine. 8. Biotechnology and Biopharmaceuticals: Showcasing the R&D achievements of biopharmaceutical companies in oncology treatment, including novel antibody drugs, vaccines, biosimilars, etc. 9. Patient Education and Support: Providing cancer patient education materials, disease management tools, patient support organization information, etc., to help patients better understand and manage their disease. 10. Cancer Prevention and Health Management: Involving cancer risk assessment, lifestyle interventions, vaccination, and other preventive measures, as well as health management products and services. In addition, the congress also features various formats such as workshops, oral presentations, and poster sessions, covering a wide range of topics from basic research to clinical application, from rare cancers to common tumors, from drug approval to oncology care, ensuring that attendees can gain a comprehensive understanding of the latest developments and trends in oncology.

No fee information available. Please contact us for a quote.